New Bioprinting Technique Accelerates Tissue Fabrication

Penn State researchers have developed a novel bioprinting method that significantly enhances the speed and precision of tissue fabrication. The new technique, called High-throughput Integrated Tissue Fabrication System for Bioprinting (HITS-Bio), uses spheroids to create complex tissue structures at an unprecedented rate.

HITS-Bio employs a digitally controlled nozzle array that can manipulate multiple spheroids simultaneously. This innovation allows for the rapid construction of scalable structures, operating ten times faster than existing techniques while maintaining over 90% cell viability. The system's efficiency was demonstrated by fabricating a one-cubic centimeter cartilage structure containing approximately 600 spheroids in less than 40 minutes.

The technique's potential for clinical applications was showcased through intraoperative bioprinting in a rat model. Spheroids were printed directly into a skull wound site during surgery, programmed to transform into bone using microRNA technology. This resulted in 91% wound healing after three weeks and 96% after six weeks.

Ibrahim T. Ozbolat, senior author of the paper published in Nature Communications, emphasized the significance of this advancement: "This technique is a significant advancement in rapid bioprinting of spheroids. It enables the bioprinting of tissues in a high-throughput manner at a speed much faster than existing techniques with high cell viability." 

The HITS-Bio method addresses key challenges in tissue engineering, such as achieving high cell density and precise spheroid placement. It opens new possibilities for developing functional tissues and organs, potentially transforming regenerative medicine.

Future developments aim to incorporate blood vessels into fabricated tissue and expand the nozzle array for larger, more intricate structures. This progress could lead to the production of complex tissues suitable for clinical use or transplantation.